BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9430408)

  • 1. Effects of the putative dopamine D3 receptor antagonist PNU 99194A on motor behavior and emotional reactivity in C57BL/6J mice.
    Gendreau PL; Petitto JM; Schnauss R; Frantz KJ; Van Hartesveldt C; Gariépy JL; Lewis MH
    Eur J Pharmacol; 1997 Oct; 337(2-3):147-55. PubMed ID: 9430408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.
    Baker LE; Miller ME; Svensson KA
    Behav Pharmacol; 1997 Jun; 8(2-3):243-52. PubMed ID: 9833019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D3 preferring antagonist PNU-99194a: an analysis of possible mechanisms.
    Goudie AJ; Baker LE; Smith JA; Prus AJ; Svensson KA; Cortes-Burgos LA; Wong EH; Haadsma-Svensson S
    Behav Pharmacol; 2001 Sep; 12(5):303-15. PubMed ID: 11710745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT.
    Depoortere R; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 2000 Jan; 65(1):31-4. PubMed ID: 10638632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
    Gyertyán I; Sághy K
    Behav Pharmacol; 2004 Jul; 15(4):253-62. PubMed ID: 15252275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonist.
    Baker LE; Prus AJ
    Pharmacol Biochem Behav; 2002 Nov; 73(4):753-8. PubMed ID: 12213519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
    Baker LE; Svensson KA; Garner KJ; Goodwin AK
    Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both dopamine and the putative dopamine D3 receptor antagonist PNU-99194A induce a biphasic inhibition of phorbol ester-stimulated arachidonic acid release from CHO cells transfected with the dopamine D3 receptor.
    Nilsson CL; Hellstrand M; Ekman A; Eriksson E
    Life Sci; 1999; 64(11):939-51. PubMed ID: 10201643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A.
    Franklin SR; Baker LE; Svensson KA
    Psychopharmacology (Berl); 1998 Jul; 138(1):40-6. PubMed ID: 9694525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice.
    Boulay D; Depoortere R; Rostene W; Perrault G; Sanger DJ
    Neuropharmacology; 1999 Apr; 38(4):555-65. PubMed ID: 10221759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic-like effect of nafadotride and PNU 99194A, dopamine D3 receptor antagonists in animal models.
    Rogóz Z; Kłodzińska A; Maj J
    Pol J Pharmacol; 2000; 52(6):459-62. PubMed ID: 11334239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine D3 antagonist U-99194A maleate increases social behaviors of isolation-induced aggressive male mice.
    Rodríguez-Arias M; Felip CM; Broseta I; Miñarro J
    Psychopharmacology (Berl); 1999 May; 144(1):90-4. PubMed ID: 10379629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of ethanol reward by dopamine D3 receptor blockade.
    Boyce JM; Risinger FO
    Brain Res; 2000 Oct; 880(1-2):202-6. PubMed ID: 11033008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice.
    Manzanedo C; Aguilar MA; Miñarro J
    Psychopharmacology (Berl); 1999 Mar; 143(1):82-8. PubMed ID: 10227083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach.
    Clifford JJ; Waddington JL
    Psychopharmacology (Berl); 1998 Apr; 136(3):284-90. PubMed ID: 9566814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D(3) and D(2) dopamine receptor agonists differentially modulate isolation-induced social-emotional reactivity in mice.
    Gendreau PL; Petitto JM; Petrova A; Gariépy J; Lewis MH
    Behav Brain Res; 2000 Sep; 114(1-2):107-17. PubMed ID: 10996052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys.
    Claytor R; Lile JA; Nader MA
    Pharmacol Biochem Behav; 2006 Mar; 83(3):456-64. PubMed ID: 16631246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA; Fujiwara RA
    Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 receptors are involved in amphetamine-induced contralateral rotation in 6-OHDA lesioned rats.
    Robinet PM; Bardo MT
    Pharmacol Biochem Behav; 2001 Sep; 70(1):43-54. PubMed ID: 11566141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.